5-HT2B/5-HT7 receptor antagonists (Astellas)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT2B/5-HT7 receptor antagonists (Astellas)
Drug Alias NameASP-1017
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonistsSerotonin 7 (5-HT7) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptorSerotonin 7 (5-HT7) receptor
Therapy Area/IndicationsMigraine DisordersIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsMigraine DisordersIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A